Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：103 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Bevacizumab market in this environment. In terms of revenue, this research report indicated that the global Bevacizumab market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Bevacizumab industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Genentech aims at producing XX Bevacizumab in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bevacizumab Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Bevacizumab Market? Genentech Amgen Allergan Roche ... Major Type of Bevacizumab Covered in XYZResearch report: 100mg 400mg Application Segments Covered in XYZResearch Market Cancer Eye Diease Application 3 For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Bevacizumab Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 100mg -Product Introduction and Major Manufacturers 1.1.2 400mg -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Bevacizumab Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Bevacizumab Market 3.1.1 Top Companies leading Bevacizumab Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Bevacizumab Market 3.2.1 Top Companies leading Bevacizumab Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Bevacizumab Market 3.3.1 Top Companies leading Bevacizumab Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Bevacizumab Market 3.4.1 Top Companies leading Bevacizumab Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Bevacizumab Market 3.5.1 Top Companies leading Bevacizumab Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Bevacizumab Market 3.6.1 Top Companies leading Bevacizumab Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Bevacizumab Market 3.7.1 Top Companies leading Bevacizumab Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Bevacizumab Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Bevacizumab Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Bevacizumab Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Bevacizumab Sales and Growth Rate (2021-2026) 5.2 Global Bevacizumab Sales Value and Growth Rate (2021-2026) 6 Bevacizumab Competitive Analysis 6.1 Genentech 6.1.1 Genentech Company Profiles 6.1.2 Genentech Product Introduction 6.1.3 Genentech Bevacizumab Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Amgen 6.2.1 Amgen Company Profiles 6.2.2 Amgen Product Introduction 6.2.3 Amgen Bevacizumab Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Allergan 6.3.1 Allergan Company Profiles 6.3.2 Allergan Product Introduction 6.3.3 Allergan Bevacizumab Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Roche 6.4.1 Roche Company Profiles 6.4.2 Roche Product Introduction 6.4.3 Roche Bevacizumab Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Bevacizumab Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Bevacizumab Sales (K Unit) by Type (2015-2026) Figure Global Bevacizumab Sales (K Unit) and Growth Rate (2015-2026) Figure Global Bevacizumab Sales Market Share (%) by Type (2019 -2020) Table Global Bevacizumab Sales Value (Million USD) by Type (2015-2026) Figure Global Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Bevacizumab Sales Value Market Share (%) by Type (2019-2020) Table Global Bevacizumab Sales (K Unit) by Application (2015-2026) Table China Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table China Bevacizumab Sales Market Share of Major Company (2015-2020) Table China Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure China Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table China Bevacizumab Sales Value Share of Major Company (2015-2020) Table China Bevacizumab Price (USD/Unit), by Type (2019-2020) Table China Bevacizumab Sales (Unit) by Type (2015-2026) Figure China Bevacizumab Sales (Unit) by Type (2015-2026) Table EU Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table EU Bevacizumab Sales Market Share of Major Company (2015-2020) Table EU Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure EU Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Bevacizumab Sales Value Share of Major Company (2015-2020) Table EU Bevacizumab Price (USD/Unit), by Type (2019-2020) Table EU Bevacizumab Sales (Unit) by Type (2015-2026) Figure EU Bevacizumab Sales (Unit) by Type (2015-2026) Table USA Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table USA Bevacizumab Sales Market Share of Major Company (2015-2020) Table USA Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure USA Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Bevacizumab Sales Value Share of Major Company (2015-2020) Table USA Bevacizumab Price (USD/Unit), by Type (2019-2020) Table USA Bevacizumab Sales (Unit) by Type (2015-2026) Figure USA Bevacizumab Sales (Unit) by Type (2015-2026) Table Japan Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table Japan Bevacizumab Sales Market Share of Major Company (2015-2020) Table Japan Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Bevacizumab Sales Value Share of Major Company (2015-2020) Table Japan Bevacizumab Price (USD/Unit), by Type (2019-2020) Table Japan Bevacizumab Sales (Unit) by Type (2015-2026) Figure Japan Bevacizumab Sales (Unit) by Type (2015-2026) Table India Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table India Bevacizumab Sales Market Share of Major Company (2015-2020) Table India Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure India Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table India Bevacizumab Sales Value Share of Major Company (2015-2020) Table India Bevacizumab Price (USD/Unit), by Type (2019-2020) Table India Bevacizumab Sales (Unit) by Type (2015-2026) Figure India Bevacizumab Sales (Unit) by Type (2015-2026) Table Southeast Asia Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Bevacizumab Sales Market Share of Major Company (2015-2020) Table Southeast Asia Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Bevacizumab Sales Value Share of Major Company (2015-2020) Table Southeast Asia Bevacizumab Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Bevacizumab Sales (Unit) by Type (2015-2026) Figure Southeast Asia Bevacizumab Sales (Unit) by Type (2015-2026) Table South America Bevacizumab Sales (K Unit) of Major Company (2015-2020) Table South America Bevacizumab Sales Market Share of Major Company (2015-2020) Table South America Bevacizumab Sales Value (Million USD) of Major Company (2015-2020) Figure South America Bevacizumab Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Bevacizumab Sales Value Share of Major Company (2015-2020) Table South America Bevacizumab Price (USD/Unit), by Type (2019-2020) Table South America Bevacizumab Sales (Unit) by Type (2015-2026) Figure South America Bevacizumab Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Bevacizumab Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Bevacizumab Figure Cost Structure of Bevacizumab in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Bevacizumab Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Bevacizumab Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Genentech Profiles Table Genentech Bevacizumab Product Introduction Table Genentech Bevacizumab Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Genentech SWOT Analysis Table Amgen Profiles Table Amgen Bevacizumab Product Introduction Table Amgen Bevacizumab Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Amgen SWOT Analysis Table Allergan Profiles Table Allergan Bevacizumab Product Introduction Table Allergan Bevacizumab Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Allergan SWOT Analysis Table Roche Profiles Table Roche Bevacizumab Product Introduction Table Roche Bevacizumab Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
